MetaADEDB 2.0 @ LMMD
CID 129626832
(BVISQZFBLRSESR-XSCWXTNMSA-N)
Structure
SMILES
NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NC(C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)C)[C@H](O)C)Cc1cnc[nH]1)CC(C)C)CCCCN)(C)C)CC(C)C)CC(C)C)CCCCN)CCC(=O)O)CC(C)C)CC(C)C)CCC(=O)O)CCCNC(=N)N)CCCNC(=N)N)CCCNC(=N)N)CC(C)C)CC(=O)O)CCC(=O)N)[C@H](CC)C)CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)C)CO)CCC(=O)O)Cc1cnc[nH]1)CCC(=O)N)CC(C)C)CC(C)C)Cc1cnc[nH]1)CC(=O)O)CCCCN
Molecular Formula:
C174H300N56O49
Molecular Weight:
3960.590
Log P:
6.6678
Hydrogen Bond Acceptor:
102
Hydrogen Bond Donor:
61
TPSA:
1738.6
CAS Number(s):
247062-33-5
Synonym(s)
1.
CID 129626832
2.
Abaloparatide
External Link(s)
PubChem Compound76943386
129626832
BindingDB50246337
CHEMBLCHEMBL4084894
DrugCentral5232
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1HeadacheFAERS: 684US FAERS
2NauseaFAERS: 559US FAERS
3Product dose omissionFAERS: 493US FAERS
4DizzinessFAERS: 429US FAERS
5FatigueFAERS: 334US FAERS
6PalpitationsFAERS: 334US FAERS
7Product quality issueFAERS: 286US FAERS
8Wrong technique in product usage processFAERS: 251US FAERS
9Back PainFAERS: 214US FAERS
10Drug dose omissionFAERS: 189US FAERS
11ArthralgiaFAERS: 160US FAERS
12PainFAERS: 152US FAERS
13Bone painFAERS: 148US FAERS
14Injection site bruisingFAERS: 128US FAERS
15Injection site painFAERS: 123US FAERS
16Adverse eventFAERS: 117US FAERS
17Feeling abnormalFAERS: 116US FAERS
18Product storage errorFAERS: 114US FAERS
19Needle issueFAERS: 113US FAERS
20MalaiseFAERS: 111US FAERS
21VomitingFAERS: 111US FAERS
22MyalgiaFAERS: 81US FAERS
23AstheniaFAERS: 66US FAERS
24Product use issueFAERS: 61US FAERS
25Abdominal discomfortFAERS: 55US FAERS
26VertigoFAERS: 50US FAERS
27ConstipationFAERS: 49US FAERS
28Abdominal PainFAERS: 46US FAERS
29AlopeciaFAERS: 44US FAERS
30Memory impairmentFAERS: 44US FAERS
31Injection site erythemaFAERS: 41US FAERS
32Chest discomfortFAERS: 40US FAERS
33AnxietyFAERS: 39US FAERS
34Chest PainFAERS: 39US FAERS
35TachycardiaFAERS: 39US FAERS
36Neck PainFAERS: 37US FAERS
37PruritusFAERS: 36US FAERS
38FlushingFAERS: 35US FAERS
39HypersensitivityFAERS: 34US FAERS
40TremorFAERS: 33US FAERS
41Musculoskeletal PainFAERS: 31US FAERS
42Peripheral swellingFAERS: 29US FAERS
43Urinary tract infectionFAERS: 28US FAERS
44Injection site pruritusFAERS: 26US FAERS
45TinnitusFAERS: 24US FAERS
46Weight decreasedFAERS: 24US FAERS
47Head discomfortFAERS: 23US FAERS
48HypotensionFAERS: 22US FAERS
49Drug ineffectiveFAERS: 21US FAERS
50ErythemaFAERS: 21US FAERS
51NasopharyngitisFAERS: 21US FAERS
52Visual ImpairmentFAERS: 21US FAERS
53ChillsFAERS: 20US FAERS
54Injection Site ReactionFAERS: 20US FAERS
55NephrolithiasisFAERS: 19US FAERS
56InfluenzaFAERS: 18US FAERS
57DyspepsiaFAERS: 17US FAERS
58Joint swellingFAERS: 17US FAERS
59NervousnessFAERS: 17US FAERS
60SomnolenceFAERS: 17US FAERS
61UrticariaFAERS: 17US FAERS
62ToothacheFAERS: 16US FAERS
63Musculoskeletal stiffnessFAERS: 15US FAERS
64Product use complaintFAERS: 15US FAERS
65SinusitisFAERS: 15US FAERS
66Burning sensationFAERS: 14US FAERS
67Inappropriate schedule of drug administrationFAERS: 14US FAERS
68Musculoskeletal discomfortFAERS: 14US FAERS
69No adverse eventFAERS: 14US FAERS
70SwellingFAERS: 14US FAERS
71Atrial FibrillationFAERS: 13US FAERS
72LethargyFAERS: 13US FAERS
73Therapy cessationFAERS: 13US FAERS
74Blood alkaline phosphatase increasedFAERS: 12US FAERS
75DysgeusiaFAERS: 12US FAERS
76PneumoniaFAERS: 12US FAERS
77Cerebrovascular accidentFAERS: 11US FAERS
78Expired product administeredFAERS: 11US FAERS
79InfectionFAERS: 10US FAERS
80Injection site urticariaFAERS: 10US FAERS
81Liquid product physical issueFAERS: 9US FAERS
82Medication ErrorFAERS: 9US FAERS
83ArthritisFAERS: 8US FAERS
84ArthropathyFAERS: 8US FAERS
85Feeling jitteryFAERS: 8US FAERS
86Injury associated with deviceFAERS: 8US FAERS
87Limb discomfortFAERS: 8US FAERS
88Muscle tightnessFAERS: 8US FAERS
89OverdoseFAERS: 8US FAERS
90Accidental overdoseFAERS: 7US FAERS
91FlatulenceFAERS: 7US FAERS
92Loss of personal independence in daily activitiesFAERS: 7US FAERS
93Multiple allergiesFAERS: 7US FAERS
94Oropharyngeal painFAERS: 7US FAERS
95RetchingFAERS: 7US FAERS
96ThirstFAERS: 7US FAERS
97Urine output increasedFAERS: 7US FAERS
98DiscomfortFAERS: 6US FAERS
99Dry skinFAERS: 6US FAERS
100Ear discomfortFAERS: 6US FAERS
101Eye painFAERS: 6US FAERS
102Feeling ColdFAERS: 6US FAERS
103Rash erythematousFAERS: 6US FAERS
104Cardiac FlutterFAERS: 5US FAERS
105DisorientationFAERS: 5US FAERS
106Drug administration errorFAERS: 5US FAERS
107DysuriaFAERS: 5US FAERS
108Gastric pH decreasedFAERS: 5US FAERS
109HypersomniaFAERS: 5US FAERS
110Incorrect dose administeredFAERS: 5US FAERS
111Incorrect route of product administrationFAERS: 5US FAERS
112Limb injuryFAERS: 5US FAERS
113Myocardial InfarctionFAERS: 5US FAERS
114NocturiaFAERS: 5US FAERS
115OnychoclasisFAERS: 5US FAERS
116Poor quality sleepFAERS: 5US FAERS
117Product administered at inappropriate siteFAERS: 5US FAERS
118Product complaintFAERS: 5US FAERS
119Product container issueFAERS: 5US FAERS
120SyncopeFAERS: 5US FAERS
121Therapeutic response unexpectedFAERS: 5US FAERS
122AcneFAERS: 4US FAERS
123AgitationFAERS: 4US FAERS
124AmnesiaFAERS: 4US FAERS
125Arthropod biteFAERS: 4US FAERS
126Blood pressure fluctuationFAERS: 4US FAERS
127Bone density decreasedFAERS: 4US FAERS
128CystitisFAERS: 4US FAERS
129DehydrationFAERS: 4US FAERS
130EpistaxisFAERS: 4US FAERS
131Fear of fallingFAERS: 4US FAERS
132FibromyalgiaFAERS: 4US FAERS
133FractureFAERS: 4US FAERS
134Inappropriate schedule of product administrationFAERS: 4US FAERS
135Intestinal ObstructionFAERS: 4US FAERS
136Joint injuryFAERS: 4US FAERS
137Joint stiffnessFAERS: 4US FAERS
138Muscle strainFAERS: 4US FAERS
139PresyncopeFAERS: 4US FAERS
140Renal painFAERS: 4US FAERS
141Sensation of blood flowFAERS: 4US FAERS
142Skin lacerationFAERS: 4US FAERS
143SluggishnessFAERS: 4US FAERS
144StressFAERS: 4US FAERS
145Throat irritationFAERS: 4US FAERS
146Waist circumference increasedFAERS: 4US FAERS
147Wrong technique in device usage processFAERS: 4US FAERS
148Accidental underdoseFAERS: 3US FAERS
149Ankle FractureFAERS: 3US FAERS
150AsthmaFAERS: 3US FAERS
151Blood glucose decreasedFAERS: 3US FAERS
152Blood potassium increasedFAERS: 3US FAERS
153Blood urine presentFAERS: 3US FAERS
154Cardiac discomfortFAERS: 3US FAERS
155CryingFAERS: 3US FAERS
156Depressed moodFAERS: 3US FAERS
157Device use issueFAERS: 3US FAERS
158DysphoniaFAERS: 3US FAERS
159EructationFAERS: 3US FAERS
160Growing painsFAERS: 3US FAERS
161HerniaFAERS: 3US FAERS
162Impaired driving abilityFAERS: 3US FAERS
163InflammationFAERS: 3US FAERS
164Injection site discomfortFAERS: 3US FAERS
165Injection site vesiclesFAERS: 3US FAERS
166Multiple use of single-use productFAERS: 3US FAERS
167NeuralgiaFAERS: 3US FAERS
168Night sweatsFAERS: 3US FAERS
169PhotophobiaFAERS: 3US FAERS
170Restless Legs SyndromeFAERS: 3US FAERS
171RestlessnessFAERS: 3US FAERS
172Serum procollagen type I N-terminal propeptide decreasedFAERS: 3US FAERS
173Skin irritationFAERS: 3US FAERS
174Skin texture abnormalFAERS: 3US FAERS
175Spinal column stenosisFAERS: 3US FAERS
176StomatitisFAERS: 3US FAERS
177TachyphreniaFAERS: 3US FAERS
178ThrombosisFAERS: 3US FAERS
179TrismusFAERS: 3US FAERS
180WheezingFAERS: 3US FAERS
181Accidental exposure to productFAERS: 2US FAERS
182AngerFAERS: 2US FAERS
183ApathyFAERS: 2US FAERS
184AphasiaFAERS: 2US FAERS
185AphoniaFAERS: 2US FAERS
186Back disorderFAERS: 2US FAERS
187BlepharospasmFAERS: 2US FAERS
188Blood cholesterol increasedFAERS: 2US FAERS
189Blood glucose increasedFAERS: 2US FAERS
190Bowel movement irregularityFAERS: 2US FAERS
191BronchitisFAERS: 2US FAERS
192ChromatopsiaFAERS: 2US FAERS
193Cold sweatFAERS: 2US FAERS
194DeafnessFAERS: 2US FAERS
195Delayed sleep phaseFAERS: 2US FAERS
196DyscheziaFAERS: 2US FAERS
197EczemaFAERS: 2US FAERS
198Elective procedureFAERS: 2US FAERS
199Emotional disorderFAERS: 2US FAERS
200Emotional distressFAERS: 2US FAERS
201Excessive cerumen productionFAERS: 2US FAERS
202Eye irritationFAERS: 2US FAERS
203Food PoisoningFAERS: 2US FAERS
204Food aversionFAERS: 2US FAERS
205Gastric DilatationFAERS: 2US FAERS
206GlaucomaFAERS: 2US FAERS
207HemiparesisFAERS: 2US FAERS
208Hip surgeryFAERS: 2US FAERS
209HyperthyroidismFAERS: 2US FAERS
210HypogeusiaFAERS: 2US FAERS
211Impaired quality of lifeFAERS: 2US FAERS
212Impaired work abilityFAERS: 2US FAERS
213Inability to afford medicationFAERS: 2US FAERS
214Incision site vesiclesFAERS: 2US FAERS
215Incorrect dose administered by deviceFAERS: 2US FAERS
216Increased upper airway secretionFAERS: 2US FAERS
217Increased viscosity of upper respiratory secretionFAERS: 2US FAERS
218Injection site drynessFAERS: 2US FAERS
219Injection site massFAERS: 2US FAERS
220Lactose IntoleranceFAERS: 2US FAERS
221LaryngitisFAERS: 2US FAERS
222Limb massFAERS: 2US FAERS
223Medical device removalFAERS: 2US FAERS
224Musculoskeletal chest painFAERS: 2US FAERS
225Nerve injuryFAERS: 2US FAERS
226Oral painFAERS: 2US FAERS
227Pain of skinFAERS: 2US FAERS
228PancreatitisFAERS: 2US FAERS
229Product administration errorFAERS: 2US FAERS
230Product contamination with body fluidFAERS: 2US FAERS
231Product expiration date issueFAERS: 2US FAERS
232Product leakageFAERS: 2US FAERS
233Product physical issueFAERS: 2US FAERS
234Respiratory tract congestionFAERS: 2US FAERS
235Rheumatoid ArthritisFAERS: 2US FAERS
236RosaceaFAERS: 2US FAERS
237Sight disabilityFAERS: 2US FAERS
238Skin lesionFAERS: 2US FAERS
239Soft tissue massFAERS: 2US FAERS
240Supraventricular tachycardiaFAERS: 2US FAERS
241Syringe issueFAERS: 2US FAERS
242Thoracic vertebral fractureFAERS: 2US FAERS
243ThrombocytopeniaFAERS: 2US FAERS
244Tongue pruritusFAERS: 2US FAERS
245UlcerFAERS: 2US FAERS
246Unevaluable eventFAERS: 2US FAERS
247Urine calcium increasedFAERS: 2US FAERS
248Walking aid userFAERS: 2US FAERS
249Abdominal rigidityFAERS: 1US FAERS
250Abdominal tendernessFAERS: 1US FAERS
251Acute kidney injuryFAERS: 1US FAERS
252Adnexa uteri painFAERS: 1US FAERS
253Alanine Aminotransferase IncreasedFAERS: 1US FAERS
254Angina PectorisFAERS: 1US FAERS
255AppendicitisFAERS: 1US FAERS
256Atrial FlutterFAERS: 1US FAERS
257Atypical pneumoniaFAERS: 1US FAERS
258AuraFAERS: 1US FAERS
259BedriddenFAERS: 1US FAERS
260Bladder painFAERS: 1US FAERS
261Bladder spasmFAERS: 1US FAERS
262BlepharitisFAERS: 1US FAERS
263BlindnessFAERS: 1US FAERS
264Blood blisterFAERS: 1US FAERS
265Blood calcium abnormalFAERS: 1US FAERS
266Blood count abnormalFAERS: 1US FAERS
267Blood glucose abnormalFAERS: 1US FAERS
268Blood glucose fluctuationFAERS: 1US FAERS
269Blood iron abnormalFAERS: 1US FAERS
270Blood iron decreasedFAERS: 1US FAERS
271Blood parathyroid hormone abnormalFAERS: 1US FAERS
272Blood parathyroid hormone decreasedFAERS: 1US FAERS
273Blood parathyroid hormone increasedFAERS: 1US FAERS
274Blood phosphorus increasedFAERS: 1US FAERS
275Blood sodium decreasedFAERS: 1US FAERS
276Blood urea increasedFAERS: 1US FAERS
277Bone density abnormalFAERS: 1US FAERS
278BradyphreniaFAERS: 1US FAERS
279Breast tendernessFAERS: 1US FAERS
280Carotid artery occlusionFAERS: 1US FAERS
281Cataract operationFAERS: 1US FAERS
282CheilitisFAERS: 1US FAERS
283ChemotherapyFAERS: 1US FAERS
284ChromaturiaFAERS: 1US FAERS
285Cluster HeadacheFAERS: 1US FAERS
286ColitisFAERS: 1US FAERS
287Creatinine renal clearance increasedFAERS: 1US FAERS
288Dental Restoration FailureFAERS: 1US FAERS
289Dental cariesFAERS: 1US FAERS
290Device breakageFAERS: 1US FAERS
291Device leakageFAERS: 1US FAERS
292DisabilityFAERS: 1US FAERS
293Disease ProgressionFAERS: 1US FAERS
294Diverticular perforationFAERS: 1US FAERS
295DiverticulitisFAERS: 1US FAERS
296Drug administered at inappropriate siteFAERS: 1US FAERS
297Drug dispensing errorFAERS: 1US FAERS
298Drug dose omission by deviceFAERS: 1US FAERS
299Drug prescribing errorFAERS: 1US FAERS
300DysarthriaFAERS: 1US FAERS
301DysphemiaFAERS: 1US FAERS
302Ear congestionFAERS: 1US FAERS
303Endodontic procedureFAERS: 1US FAERS
304Epigastric discomfortFAERS: 1US FAERS
305EpilepsyFAERS: 1US FAERS
306Essential TremorFAERS: 1US FAERS
307Euphoric moodFAERS: 1US FAERS
308Exfoliative rashFAERS: 1US FAERS
309External ear painFAERS: 1US FAERS
310Extraocular Muscle ParesisFAERS: 1US FAERS
311Eye InfectionFAERS: 1US FAERS
312Eye symptomFAERS: 1US FAERS
313Eyelid rashFAERS: 1US FAERS
314Eyelids pruritusFAERS: 1US FAERS
315Feeling of body temperature changeFAERS: 1US FAERS
316Flank PainFAERS: 1US FAERS
317Food cravingFAERS: 1US FAERS
318FormicationFAERS: 1US FAERS
319Gastric ulcerFAERS: 1US FAERS
320GastritisFAERS: 1US FAERS
321Gastrointestinal PainFAERS: 1US FAERS
322Gastrointestinal infectionFAERS: 1US FAERS
323Gastrointestinal sounds abnormalFAERS: 1US FAERS
324Gastrointestinal ulcerFAERS: 1US FAERS
325General physical health deteriorationFAERS: 1US FAERS
326Granuloma AnnulareFAERS: 1US FAERS
327Grip strength decreasedFAERS: 1US FAERS
328HyperkeratosisFAERS: 1US FAERS
329HyperparathyroidismFAERS: 1US FAERS
330HyperventilationFAERS: 1US FAERS
331HypophagiaFAERS: 1US FAERS
332HypothyroidismFAERS: 1US FAERS
333Idiopathic Pulmonary FibrosisFAERS: 1US FAERS
334Immune thrombocytopenic purpuraFAERS: 1US FAERS
335Incorrect dose administered by productFAERS: 1US FAERS
336Injection related reactionFAERS: 1US FAERS
337Injection site extravasationFAERS: 1US FAERS
338Injection site hypersensitivityFAERS: 1US FAERS
339Injection site hypertrophyFAERS: 1US FAERS
340Injection site inflammationFAERS: 1US FAERS
341Injection site irritationFAERS: 1US FAERS
342Injection site noduleFAERS: 1US FAERS
343Injection site scabFAERS: 1US FAERS
344Insurance issueFAERS: 1US FAERS
345Intentional product use issueFAERS: 1US FAERS
346Intervertebral disc disorderFAERS: 1US FAERS
347Intestinal PerforationFAERS: 1US FAERS
348Joint Range of Motion DecreasedFAERS: 1US FAERS
349LacerationFAERS: 1US FAERS
350Lack of spontaneous speechFAERS: 1US FAERS
351Limb operationFAERS: 1US FAERS
352Lip swellingFAERS: 1US FAERS
353Loose toothFAERS: 1US FAERS
354Low density lipoprotein increasedFAERS: 1US FAERS
355Lower respiratory tract congestionFAERS: 1US FAERS
356Lupus-like syndromeFAERS: 1US FAERS
357Lymphocyte count abnormalFAERS: 1US FAERS
358MaculeFAERS: 1US FAERS
359MalabsorptionFAERS: 1US FAERS
360Mandibular massFAERS: 1US FAERS
361Medical device site joint infectionFAERS: 1US FAERS
362Mental impairmentFAERS: 1US FAERS
363Middle insomniaFAERS: 1US FAERS
364Motion SicknessFAERS: 1US FAERS
365Mouth swellingFAERS: 1US FAERS
366Muscle FatigueFAERS: 1US FAERS
367Myasthenia GravisFAERS: 1US FAERS
368NarcolepsyFAERS: 1US FAERS
369Nasal discomfortFAERS: 1US FAERS
370NoduleFAERS: 1US FAERS
371Ocular discomfortFAERS: 1US FAERS
372Off label use of deviceFAERS: 1US FAERS
373OnychomycosisFAERS: 1US FAERS
374Oral mucosal eruptionFAERS: 1US FAERS
375Orthostatic hypertensionFAERS: 1US FAERS
376Osteitis DeformansFAERS: 1US FAERS
377OsteomalaciaFAERS: 1US FAERS
378OsteomyelitisFAERS: 1US FAERS
379Palmar erythemaFAERS: 1US FAERS
380Paranasal sinus discomfortFAERS: 1US FAERS
381Pelvic Floor Muscle WeaknessFAERS: 1US FAERS
382Pelvic PainFAERS: 1US FAERS
383Pelvic discomfortFAERS: 1US FAERS
384Pericardial effusionFAERS: 1US FAERS
385Peripheral arterial occlusive diseaseFAERS: 1US FAERS
386Plantar erythemaFAERS: 1US FAERS
387Polymyalgia RheumaticaFAERS: 1US FAERS
388Poor peripheral circulationFAERS: 1US FAERS
389Portal HypertensionFAERS: 1US FAERS
390Post procedural complicationFAERS: 1US FAERS
391Post-traumatic painFAERS: 1US FAERS
392Postoperative wound complicationFAERS: 1US FAERS
393Procedural shockFAERS: 1US FAERS
394Procollagen type I C-terminal propeptide increasedFAERS: 1US FAERS
395Product administration interruptedFAERS: 1US FAERS
396Product contaminationFAERS: 1US FAERS
397Product distribution issueFAERS: 1US FAERS
398Product intoleranceFAERS: 1US FAERS
399Product use in unapproved indicationFAERS: 1US FAERS
400Protein total abnormalFAERS: 1US FAERS
401Protein total decreasedFAERS: 1US FAERS
402ProteinuriaFAERS: 1US FAERS
403PsoriasisFAERS: 1US FAERS
404Pulmonary EmbolismFAERS: 1US FAERS
405Pulmonary congestionFAERS: 1US FAERS
406PurpuraFAERS: 1US FAERS
407PyelonephritisFAERS: 1US FAERS
408Quality of life decreasedFAERS: 1US FAERS
409Radiation associated painFAERS: 1US FAERS
410Reflux gastritisFAERS: 1US FAERS
411Renal cystFAERS: 1US FAERS
412Respiratory FailureFAERS: 1US FAERS
413Respiratory distressFAERS: 1US FAERS
414Rotator cuff syndromeFAERS: 1US FAERS
415SarcoidosisFAERS: 1US FAERS
416ScabFAERS: 1US FAERS
417SciaticaFAERS: 1US FAERS
418Secretion dischargeFAERS: 1US FAERS
419Self-induced vomitingFAERS: 1US FAERS
420SepsisFAERS: 1US FAERS
421SeromaFAERS: 1US FAERS
422Serum procollagen type I N-terminal propeptide increasedFAERS: 1US FAERS
423Sinus TachycardiaFAERS: 1US FAERS
424Sinus headacheFAERS: 1US FAERS
425Skeletal injuryFAERS: 1US FAERS
426Skin IndurationFAERS: 1US FAERS
427Skin UlcerFAERS: 1US FAERS
428Skin tightnessFAERS: 1US FAERS
429Sleep TalkingFAERS: 1US FAERS
430SneezingFAERS: 1US FAERS
431Spinal fusion surgeryFAERS: 1US FAERS
432Spinal rod insertionFAERS: 1US FAERS
433Spinal rod removalFAERS: 1US FAERS
434Squamous cell carcinoma of lungFAERS: 1US FAERS
435Synovial CystFAERS: 1US FAERS
436Terminal stateFAERS: 1US FAERS
437Tongue discomfortFAERS: 1US FAERS
438Tongue movement disturbanceFAERS: 1US FAERS
439Tongue spasmFAERS: 1US FAERS
440Tooth InfectionFAERS: 1US FAERS
441Tooth repairFAERS: 1US FAERS
442Toxicity to various agentsFAERS: 1US FAERS
443Tracheostomy malfunctionFAERS: 1US FAERS
444Unresponsive to stimuliFAERS: 1US FAERS
445Urinary RetentionFAERS: 1US FAERS
446Vascular painFAERS: 1US FAERS
447VertebroplastyFAERS: 1US FAERS
448Vocal cord cystFAERS: 1US FAERS
449Wrong product storedFAERS: 1US FAERS
450kyphosisFAERS: 1US FAERS
451muscle injuryFAERS: 1US FAERS
452nervous system disorderFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.